Swiss health insurance spent more on medicine than ever in 2023
Spending on medicine has been rising with demographic changes and higher priced medicine.
Keystone-SDA / Gaetan Bally
Select your language
Generated with artificial intelligence.
Listening: Swiss health insurance spent more on medicine than ever in 2023
Last year, Swiss health insurance companies spent CHF9 billion ($10.2 billion) on medicines for compulsory insurance, almost 6% more than in the previous year. And more than ever before.
Why have medication costs risen? There are various reasons: more patients, more medication per person and new, expensive therapies. According to Swiss insurance company Helsana, the general price level of new preparations has even doubled in recent years. “A little quantity and a lot of price,” concluded the authors of the Helsana Drug Report published this week.
Switzerland spent around CHF92 billion on healthcare last year. Of which CHF9 billion is for medicine.
Demographic change and chronic disease
The population is aging, which is causing healthcare spending to rise.
The number of people over 65 grew by 2.3% last year, while the permanent resident population increased by 1.7%. The need for medication also increases with age. This means that more and more people need medication, and many take not just one medication, but several.
More
More
How drug prices are negotiated in Switzerland and beyond
This content was published on
Switzerland’s pharmaceutical sector supplies drugs worldwide, but not all countries receive them with the same price tag. Here’s why.
At CHF2.8 billion, cancer and immune system drugs accounted for almost a third of total medication costs. However, they only account for 1.9% of medication purchases. The average annual costs of the five most expensive cancer drugs amounted to around CHF90,000 per patient.
Medicines with the new active ingredient semaglutide (contained in the diabetes medicine Ozempic and the weight loss product Wegovy, among others) could often not be delivered on time. Nevertheless, they caused costs of more than CHF113 million. This corresponds to an increase of almost 40%. Overall, health insurance expenditure on diabetes medication rose to around CHF455 million.
In the case of new weight loss drugs, the effect of new therapies replacing older ones is evident: Doctors have prescribed older drugs that have become cheaper over the years less often, as they are also less effective.
Getting costs under control
How to get costs under control? A proposal for a volume discount or rebate on medicine is currently being discussed in parliament (as part of the healthcare cost containment package 2).
More
More
What’s behind Switzerland’s push for drug-pricing secrecy?
This content was published on
The Swiss parliament is considering measures on drug pricing that are drawing the ire of some health experts.
Above a certain sales threshold, pharmaceutical companies would grant discounts to health insurers or reimburse costs under the proposal. The experts at Helsana see this as a solution. The Swiss pharmaceutical association Interpharma also backs this, but in return demands that price negotiations for new medicines be tackled more quickly.
The deadlines for putting medicine on the market are not being adhered to. As a result, patients are being denied access to newer, effective medicines.
Helsana’s experts also see further potential in generics: two thirds of outpatient medication costs are accounted for by generics.
Translated from German by DeepL/jdp
This news story has been written and carefully fact-checked by an external editorial team. At SWI swissinfo.ch we select the most relevant news for an international audience and use automatic translation tools such as DeepL to translate it into English. Providing you with automatically translated news gives us the time to write more in-depth articles.
If you want to know more about how we work, have a look here, if you want to learn more about how we use technology, click here, and if you have feedback on this news story please write to english@swissinfo.ch.
Popular Stories
More
Swiss Abroad
The citizenship obstacle course facing spouses of Swiss Abroad
Thieves steal precious metals from Swiss watchmaker
This content was published on
Thieves raided the factory of the Swiss watch supplier Werthanor in Le Locle in northeastern Switzerland on Thursday morning. They fled across the border to France with precious metals.
Swiss court confirms guilty verdicts against Hells Angels and Bandidos bikers
This content was published on
Bern's High Court on Thursday confirmed guilty verdicts against six Hells Angels and Bandidos bikers involved in a violent clash outside the Swiss capital in 2019.
China rejects report on Tibetans and Uyghurs in Switzerland
This content was published on
The Chinese foreign ministry on Thursday rejected a Swiss government report suggesting that China has been cracking down on Tibetans and Uighurs living in Switzerland.
Fleur Jaeggy wins 2025 Grand Prix for Swiss Literature award
This content was published on
Zurich-born writer Fleur Jaeggy is the 2025 winner of the Grand Prix for Swiss Literature, the Federal Office of Culture (FOC) announced on Thursday.
USAID funding: Swiss aid groups urge foreign minister to act
This content was published on
Swiss aid agencies and churches have urged Foreign Minister Ignazio Cassis to take action following the freeze to funds disbursed by USAID.
Switzerland to clamp down on foreign visitors’ unpaid parking fines
This content was published on
The Swiss government has agreed to crack down on parking fines and other driving-related penalties handed out to foreign visitors that go unpaid.
Streaming continues to drive Swiss music market growth
This content was published on
The Swiss music market generated sales of CHF249 million ($274 million) in 2024, up 7% on the previous year, with streaming driving most of the growth.
Migros sells Hotelplan tour operator to Germany’s Dertour
This content was published on
The Swiss retailer Migros is selling most of the Hotelplan Group to the German tour operator Dertour. Meanwhile the Hotelplan subsidiary Interhome has been sold to Hometogo.
This content was published on
The flu epidemic in Switzerland is easing. The number of reported cases fell last week, according to the Federal Office of Public Health (FOPH). But the wave may not yet have reached its peak.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.